Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Journal of the American College of Cardiology
|
December 6, 2008
Highlights of the 2008 Scientific Sessions of the European Society of Cardiology Munich, Germany, August 30 to September 3, 2008
Steen D Kristensen, Helmut Baumgartner, Barbara Casadei, et al.
Circulation
|
December 23, 2009
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy
Sajoscha A Sorrentino, Christian Besler, Lucia Rohrer, et al.
The New England Journal of Medicine
|
November 19, 2009
Ferric carboxymaltose in patients with heart failure and iron deficiency
Stefan D Anker, Josep Comin Colet, Gerasimos Filippatos, et al.
Revista Espanola De Cardiologia
|
September 28, 2005
[Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]
Karl Swedberg, John Cleland, Henry Dargie, et al.
European Heart Journal
|
May 20, 2005
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Karl Swedberg, John Cleland, Henry Dargie, et al.
Circulation
|
March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L Mann, John J V McMurray, Milton Packer, et al.
The Journal of Experimental Medicine
|
August 1, 2007
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Maren Luchtefeld, Heribert Schunkert, Monika Stoll, et al.
Cell
|
February 10, 2007
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
Denise Hilfiker-Kleiner, Karol Kaminski, Edith Podewski, et al.
European Journal of Heart Failure
|
January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Stephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
Cardiovascular Drugs and Therapy
|
July 2, 2002
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report
Victor J Dzau, Kenneth Bernstein, David Celermajer, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Journal of the American College of Cardiology
|
December 6, 2008
Highlights of the 2008 Scientific Sessions of the European Society of Cardiology Munich, Germany, August 30 to September 3, 2008
Steen D Kristensen, Helmut Baumgartner, Barbara Casadei, et al.
Circulation
|
December 23, 2009
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy
Sajoscha A Sorrentino, Christian Besler, Lucia Rohrer, et al.
The New England Journal of Medicine
|
November 19, 2009
Ferric carboxymaltose in patients with heart failure and iron deficiency
Stefan D Anker, Josep Comin Colet, Gerasimos Filippatos, et al.
Revista Espanola De Cardiologia
|
September 28, 2005
[Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]
Karl Swedberg, John Cleland, Henry Dargie, et al.
European Heart Journal
|
May 20, 2005
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Karl Swedberg, John Cleland, Henry Dargie, et al.
Circulation
|
March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L Mann, John J V McMurray, Milton Packer, et al.
The Journal of Experimental Medicine
|
August 1, 2007
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Maren Luchtefeld, Heribert Schunkert, Monika Stoll, et al.
Cell
|
February 10, 2007
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
Denise Hilfiker-Kleiner, Karol Kaminski, Edith Podewski, et al.
European Journal of Heart Failure
|
January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Stephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
Cardiovascular Drugs and Therapy
|
July 2, 2002
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report
Victor J Dzau, Kenneth Bernstein, David Celermajer, et al.
Page
of 19